Cardiotoxicities of novel cancer immunotherapies

This review describes the current understanding of the mechanisms, epidemiology and management of immunotherapy-related cardiotoxicity, focusing on immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.

Heart